Cart is empty In 2019, the World Health Organization formally recommended the drug dolutegravir (DTG) as the preferred antiretroviral therapy (ART) for people living with HIV in low and middle-income countries (LMICs), citing that it is more effective and tolerable, less costly, and less prone to developing drug resistance than the previously recommended first-line treatment efavirenz (EFV).
Slow recovery from concussion? Exercise, breathing practice may improve symptoms
Breathing practice as well as gradual aerobic exercise may help improve concussion symptoms in teens experiencing slow recovery, according to a preliminary study released today, February 21, 2023, that will be presented at the American Academy of Neurology’s 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023. The study found that while the two therapies are each beneficial separately, when combined they resulted in even greater improvement in thinking and memory skills, depression and mood.
Population-scaled, school-based physical activity intervention can help prevent childhood obesity
A new Slovenian population-scaled, school-based study shows that by providing additional physical education lessons to young children is effective in preventing childhood obesity, according to findings published in Obesity, The Obesity Society’s (TOS) flagship journal.
Study suggests dapivirine vaginal ring is safe to use as HIV prevention during breastfeeding
A monthly vaginal ring containing the antiretroviral drug dapivirine—an HIV prevention method that has been approved in several African countries and recommended by the World Health Organization (WHO) –appears to be safe when used during breastfeeding, suggest results of a Phase IIIb open-label study presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2023) in Seattle.
Fast-dissolving insert found safe, shows promise as method for preventing HIV through anal sex
A fast-dissolving insert being developed as an “on-demand” HIV prevention method was found to be safe and well-tolerated in the first study of its use rectally. The results, which were presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2023) in Seattle, also found the insert delivered high levels of the anti-retroviral drugs tenofovir alafenamide (TAF) and elvitegravir (EVG) to rectal tissue and fluid, with very little drug circulating elsewhere in the body, and results of laboratory tests suggesting the insert could potentially provide protection for up to three days after use.
Shock to the system: Study shows certain wearable gadgets could interfere with implantable cardiac electronic devices
In this high-tech era, wearable devices such as smartwatches have proven to be invaluable companions for the health conscious. But a new study from the University of Utah shows that for a small group of people, some of these electronic fitness gadgets could possibly be risky to their health—even potentially deadly.
Air Pollution Causes Bone Damage In Postmenopausal Women, Study Finds
A large study reported that air pollutants speed up the bone loss from osteoporosis.
FDA Wants To Make Opioid Overdose Antidote Accessible To Many People
Advisory committee members voted unanimously to make Narcan nasal spray available over the counter.
Ozempic Weight Loss: Interested Population Struggles To Afford $1,500 Medication
The weight loss wonder drug continues to witness skyrocketing demand amid the craze.
Bird Flu Has 56% Fatality Rate In Humans; Experts Bracing For Next Pandemic
The virus responsible for the worst bird flu outbreak in the U.S. could develop mutations for easier human transmission.